NCT01702441View on ClinicalTrials.gov

Safety and Pilot Efficacy of AKB-9778 in Subjects With Diabetic Macular Edema

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

September 30, 2013

Study Completion Date

December 31, 2014

Conditions
Diabetic Macular Edema (DME)
Interventions
DRUG

Subcutaneous AKB-9778

Trial Locations (6)

Unknown

Beverly Hills

Winter Haven

Baltimore

Boston

Charlotte

Cincinnati

Sponsors
All Listed Sponsors
lead

Aerpio Therapeutics

INDUSTRY

NCT01702441 - Safety and Pilot Efficacy of AKB-9778 in Subjects With Diabetic Macular Edema | Biotech Hunter | Biotech Hunter